石四药集团 港股通 空最新回购 (2026-01-09) 官网 ( 02005.hk) | 15.55 | 1.00 | 3.23% (3.23%) | 上市时间2005-12-20股价2.48港币涨跌幅-1.59%成交金额1,686.66万港币换手率0.23%市值73.19亿港币H股市值73.19亿港币总股本29.51亿H股本29.51亿每手股数2,000上市至今年化投资收益率4.17%港股通持仓占H股比例18.95% (14.04亿港币2026-04-15) 累计做空占H股比例5.19% (3.89亿港币2026-04-10) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 31.02 | 市净率 | 2.92 | 股息率 | 1.19% (1.18%) | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (11): | 双击编辑备注 |
石四药集团(02005) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 姜廣策 | Independent Non Executive Director | 2023-01-01 | -- | |
| 2 | 周興揚 | Executive Director | 2021-08-27 | -- | |
| 3 | 孟國 | Executive Director | 2021-08-27 | -- | |
| 4 | 馮昊 | Non Executive Director | 2017-11-24 | 2023-11-01 | |
| 5 | 蘇學軍 | Executive Director | 2014-12-15 | -- | |
| 6 | 高淑平 | Executive Director | 2009-07-29 | 2012-12-17 | |
| 7 | 包樂源 | Executive Director | 2008-09-01 | 2012-12-17 | |
| 8 | 曲繼廣 | Executive Director | CEO | 2007-07-26 | -- |
| 9 | 王亦兵 | Independent Non Executive Director | 2007-07-26 | -- | |
| 10 | 段偉 | Executive Director | 2007-07-26 | 2014-12-16 | |
| 11 | 張桂馥 | Executive Director | 2007-07-26 | 2012-04-05 | |
| 12 | 王志忠 | Executive Director | 2007-07-26 | 2009-07-29 | |
| 13 | 王憲軍 | Executive Director | 2006-09-25 | 2021-08-27 | |
| 14 | 周國偉 | Independent Non Executive Director - A/F | 2005-10-16 | -- | |
| 15 | 梁創順 | Independent Non Executive Director | 2005-10-16 | 2023-05-19 | |
| 16 | 曲繼廣 | Independent Non Executive Director | 2005-10-16 | 2007-07-26 | |
| 17 | 吳秦 | Executive Director | Chairman | 2004-12-27 | 2014-06-04 |
| 18 | 謝云峰 | Executive Director | 2004-12-27 | 2014-06-04 | |
| 19 | 黃朝 | Executive Director | 2004-12-27 | 2012-12-17 | |
| 20 | 劉志勇 | Non Executive Director | 2004-12-27 | 2011-10-17 | |
| 21 | 孫幸來 | Executive Director | 2004-12-27 | 2011-07-29 | |
| 22 | 烏志鴻 | Executive Director | 2004-12-27 | 2008-05-30 |